This proposal is part of an overall company cost reduction effort. Its main active ingredient, finasteride, is foreign-sourced and constitutes between 5 and 15 percent of the finished product's value. Zone procedures would exempt Merck from Customs duty payments on foreign materials used in production for export. The application indicates that the savings from zone procedures will help improve the firm's international competitiveness. In accordance with the Board's regulations, a member of the FTZ Staff has been designated examiner to investigate the application and report to the Board.
Public comment is invited from interested parties.
The closing period for their receipt is October 22, 1993. August 10, 1993. John J. Da Ponte, Jr., Executive Secretary.